The telomeric protein TRF2 is required to prevent mammalian telomeres from activating DNA damage checkpoints. Here we show that overexpression of TRF2 affects the response of the ATM kinase to DNA damage. Overexpression of TRF2 abrogated the cell cycle arrest after ionizing radiation and diminished several other readouts of the DNA damage response, including phosphorylation of Nbs1, induction of p53, and upregulation of p53 targets. TRF2 inhibited autophosphorylation of ATM on S1981, an early step in the activation of this kinase. A region of ATM containing S1981 was found to directly interact with TRF2 in vitro, and ATM immunoprecipitates contained TRF2. We propose that TRF2 has the ability to inhibit ATM activation at telomeres. Because TRF2 is abundant at chromosome ends but not elsewhere in the nucleus, this mechanism of checkpoint control could specifically block a DNA damage response at telomeres without affecting the surveillance of chromosome internal damage.
References
[1]
Alligood KJ, Milla M, Rhodes N, Ellis B, Kilpatrick KE, et al. (2000) Monoclonal antibodies generated against recombinant ATM support kinase activity. Hybridoma 19: 317–321.
[2]
Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499–506.
[3]
Baumann P, Cech TR (2001) Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292: 1171–1175.
[4]
Broccoli D, Smogorzewska A, Chong L, de Lange T (1997) Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 17: 231–235.
[5]
Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, et al. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677–1679.
[6]
Carson CT, Schwartz RA, Stracker TH, Lilley CE, Lee DV, et al. (2003) The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J 22: 6610–6620.
[7]
Craven RJ, Greenwell PW, Dominska M, Petes TD (2002) Regulation of genome stability by TEL1 and MEC1, yeast homologs of the mammalian ATM and ATR genes. Genetics 161: 493–507.
[8]
d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, et al. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194–198.
[9]
de Lange T (2002) Protection of mammalian telomeres. Oncogene 21: 532–540.
[10]
Fairall L, Chapman L, Moss H, de Lange T, Rhodes D (2001) Structure of the TRFH dimerization domain of the human telomeric proteins TRF1 and TRF2. Mol Cell 8: 351–361.
[11]
Garvik B, Carson M, Hartwell L (1995) Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint. Mol Cell Biol 15: 6128–6138.
[12]
Gatei M, Young D, Cerosaletti KM, Desai-Mehta A, Spring K, et al. (2000) ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat Genet 25: 115–119.
[13]
Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, et al. (1999) Mammalian telomeres end in a large duplex loop. Cell 97: 503–514.
[14]
Horvath MP, Schweiker VL, Bevilacqua JM, Ruggles JA, Schultz SC (1998) Crystal structure of the Oxytricha nova telomere end binding protein complexed with single strand DNA. Cell 95: 963–974.
[15]
Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T (1999) p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283: 1321–1325.
[16]
Karlseder J, Smogorzewska A, de Lange T (2002) Senescence induced by altered telomere state, not telomere loss. Science 295: 2446–2449.
[17]
Kastan MB, Lim DS (2000) The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1: 179–186.
[18]
Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, et al. (1998) ATM associates with and phosphorylates p53: Mapping the region of interaction. Nat Genet 20: 398–400.
[19]
Kishi S, Zhou XZ, Ziv Y, Khoo C, Hill DE, et al. (2001) Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks. J Biol Chem 276: 29282–29291.
[20]
Li B, Oestreich S, de Lange T (2000) Identification of human Rap1: Implications for telomere evolution. Cell 101: 471–483.
[21]
Lim DS, Kim ST, Xu B, Maser RS, Lin J, et al. (2000) ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404: 613–617.
[22]
Luque FA, Furneaux HM, Ferziger R, Rosenblum MK, Wray SH, et al. (1991) Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29: 241–251.
[23]
Machwe A, Xiao L, Orren DK (2004) TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA. Oncogene 23: 149–156.
[24]
Matsuura A, Naito T, Ishikawa F (1999) Genetic control of telomere integrity in Schizosaccharomyces pombe: Rad3(+) and tel1(+) are parts of two regulatory networks independent of the downstream protein kinases chk1(+) and cds1(+). Genetics 152: 1501–1512.
[25]
Opresko PL, Von Kobbe C, Laine JP, Harrigan J, Hickson ID, et al. (2002) Telomere binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J Biol Chem 277: 41110–41119.
[26]
Petrini J, Stracker T (2003) The cellular response to DNA double strand breaks: Defining the sensors and mediators. Trends Cell Biol 13: 458–462.
[27]
Schultz LB, Chehab NH, Malikzay A, Halazonetis TD (2000) p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 151: 1381–1390.
[28]
Shiloh Y (2003) ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 3: 155–168.
[29]
Smogorzewska A, de Lange T (2002) Different telomere damage signaling pathways in human and mouse cells. EMBO J 21: 4338–4348.
[30]
Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, et al. (2000) Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20: 1659–1668.
[31]
Smogorzewska A, Karlseder J, Holtgreve-Grez H, Jauch A, de Lange T (2002) DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr Biol 12: 1635–1644.
[32]
Stansel RM, de Lange T, Griffith JD (2001) T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J 20: E5532–E5540.
[33]
Takai H, Smogorzewska A, de Lange T (2003) DNA damage foci at dysfunctional telomeres. Curr Biol 13: 1549–1556.
[34]
Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, et al. (2003) Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 22: 5612–5621.
[35]
van Steensel B, Smogorzewska A, de Lange T (1998) TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401–413.
[36]
Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, et al. (2003) Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421: 643–648.
[37]
Wu X, Ranganathan V, Weisman DS, Heine WF, Ciccone DN, et al. (2000) ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405: 477–482.
[38]
Zhao S, Weng YC, Yuan SS, Lin YT, Hsu HC, et al. (2000) Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405: 473–477.
[39]
Zhu XD, Kuster B, Mann M, Petrini JH, de Lange T (2000) Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat Genet 25: 347–352.
[40]
Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, et al. (2003) ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 12: 1489–1498.
